COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIA

Three intravenous bisphosphonates were compared in the treatment of cancer-associated hypercalcaemia. 48 patients were randomly allocated to one of three treatment groups (each with 16 subjects)—30 mg pamidronate or 600 mg clodronate, both as single intravenous infusions; or etidronate as three infu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet (British edition) 1989-11, Vol.334 (8673), p.1180-1182
Hauptverfasser:	Ralston, StuartH, Patel, Uday, Fraser, WilliamD, Gallacher, StephenJ, Dryburgh, FrancesJ, Cowan, RobertA, Boyle, IainT
Format:	Artikel
Sprache:	eng
Schlagworte:	Bisphosphonates Calcium Cancer Disease Medical research Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!